NEWS
Issue 104
Distributed with Times of Malta
| November 21, 2019
Local medical cannabis companies finding banking solutions outside Malta
e Malta Business Observer interviews Lufthansa Technik Malta CEO, Marcus Motschenbacher, on the growth of the firm’s operations here in Malta. see pages 5, 6 >
Helena Grech Some medical cannabis companies in the process of getting licensed in Malta have solved their banking issues by turning to overseas banks, while Malta Enterprise CEO Kurt Farrugia reveals that three local banks are “positively considering” whether to allow the industry into their risk appetites. Earlier in November, BOV CEO Mario Mallia announced that, in line with regulators’ demands and a lack of expertise within the bank, it would not be accepting to service medical cannabis companies as the industry falls outside its risk appetite. Medical cannabis was officially legalised in Malta in March 2018, with Malta Enterprise in charge of overseeing the licensing process. Asked whether the banking situation has been a concern for Malta Enterprise, Mr Farrugia was cautiously optimistic, as companies “are finding other solutions”. He added that “some companies are using banks in Spain and Germany; big banks which are established.” In comments to The Malta Business Observer, Mr Farrugia explained that Malta Enterprise undertook an exercise whereby it communicated with all banks in Malta, as well as a number of international financial institutions, about the medical cannabis industry locally and the licensing process involved. He said that an overview was given to the banks detailing due diligence and business plan scrutiny by Malta Enterprise on each applicant company. To apply, firms need to submit details regarding company structure and the Ultimate Beneficial Own-
NEWS With Malta’s one-year transitory period for the blockchain sector having recently come to an end, Parliamentary Secretary for the Digital Economy, Financial Services and Innovation, Silvio Schembri, counters claims of slow activity in the sector. see pages 9, 13 >
TRANSPORT
ership (UBO) of shareholding. Following this, aspiring companies must seek out an EU Good Manufacturing Practice (GMP) certification. Furthermore, aspiring companies must be GMP certified in the country where the company was originally set up. In addition, the raw materials imported for production in that country – in this case, Malta – must also be EU GMP and Good Agricultural Practice (GAP) certified. Mr Farrugia highlighted that Malta Enterprise’s goal in meeting with the banks was to share knowledge about the industry and fight any misconceptions that may exist.
Currently, there are 24 medical cannabis companies that hold a Letter of Intent by Malta Enterprise – out of 50 applicants – with six at a very advanced stage. “We met each and every bank and provided an overview of the whole spectrum of companies that we have approved by issuing a Letter of Intent, and made a specific case for the medical cannabis industry in general. We aimed to share knowledge on the industry, the way it is developing
and that, at the end of it all, these aren’t companies operating in the entertainment industry. These are not recreational drugs, but products used for medical purposes, produced by pharmaceutical companies that employ continued on page 3
Car sharing platform, GoTo announces its transformation into a multi-vehicle platform, with the launch of its new scooter service in the first half of December. see pages 18, 19 >
STOCK MARKET REVIEW Edward Rizzo, director at Rizzo, Farrugia & Co (Stockbrokers) Limited, reviews the published Interim Directors’ Statements of some of Malta’s leading companies. see pages 22, 23 >